OLMESARTAN/HCTZ DIN 02509628
Health Canada record
| Active ingredient(s) | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 25 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C09DA08 OLMESARTAN MEDOXOMIL AND DIURETICS |
| Original market date | 14-Jun-2021 |
| Current status date | 13-Apr-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sanis Health Inc. — licence 101796, currently licensed, last inspection rating I (2024-07-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OLMESARTAN MEDOXOMIL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02456338 | ACH-OLMESARTAN | ACCORD HEALTHCARE INC | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Marketed |
| 02456311 | ACH-OLMESARTAN | ACCORD HEALTHCARE INC | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Marketed |
| 02468956 | ACH-OLMESARTAN HCTZ | ACCORD HEALTHCARE INC | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed |
| 02468964 | ACH-OLMESARTAN HCTZ | ACCORD HEALTHCARE INC | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed |
| 02468948 | ACH-OLMESARTAN HCTZ | ACCORD HEALTHCARE INC | Tablet | OLMESARTAN MEDOXOMIL 20 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed |
| 02453444 | APO-OLMESARTAN | APOTEX INC | Tablet | OLMESARTAN MEDOXOMIL 10 MG | Approved |
| 02443872 | AURO-OLMESARTAN | AURO PHARMA INC | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Marketed |
| 02443856 | AURO-OLMESARTAN | AURO PHARMA INC | Tablet | OLMESARTAN MEDOXOMIL 5 MG | Approved |
| 02443864 | AURO-OLMESARTAN | AURO PHARMA INC | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Marketed |
| 02469820 | GLN-OLMESARTAN | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Marketed |
| 02469812 | GLN-OLMESARTAN | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Marketed |
| 02475707 | GLN-OLMESARTAN HCTZ | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | OLMESARTAN MEDOXOMIL 20 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed |
| 02475715 | GLN-OLMESARTAN HCTZ | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed |
| 02475723 | GLN-OLMESARTAN HCTZ | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed |
| 02461668 | JAMP OLMESARTAN | JAMP PHARMA CORPORATION | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Marketed |
| 02461641 | JAMP OLMESARTAN | JAMP PHARMA CORPORATION | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Marketed |
| 02442515 | MED-OLMESARTAN | GENERIC MEDICAL PARTNERS INC | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Approved |
| 02442523 | MED-OLMESARTAN | GENERIC MEDICAL PARTNERS INC | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Approved |
| 02450054 | OLMESARTAN | JUBILANT GENERICS LIMITED | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Approved |
| 02450062 | OLMESARTAN | JUBILANT GENERICS LIMITED | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Approved |
| 02455099 | OLMESARTAN MEDOXOMIL / HYDROCHLOROTHIAZIDE | JUBILANT GENERICS LIMITED | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 25 MG | Approved |
| 02455080 | OLMESARTAN MEDOXOMIL / HYDROCHLOROTHIAZIDE | JUBILANT GENERICS LIMITED | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Approved |
| 02455072 | OLMESARTAN MEDOXOMIL / HYDROCHLOROTHIAZIDE | JUBILANT GENERICS LIMITED | Tablet | OLMESARTAN MEDOXOMIL 20 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Approved |
| 02318660 | OLMETEC | ORGANON CANADA INC. | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Marketed |
| 02318679 | OLMETEC | ORGANON CANADA INC. | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Marketed |
| 02318652 | OLMETEC | ORGANON CANADA INC. | Tablet | OLMESARTAN MEDOXOMIL 5 MG | Approved |
| 02319632 | OLMETEC PLUS | ORGANON CANADA INC. | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed |
| 02319624 | OLMETEC PLUS | ORGANON CANADA INC. | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed |
| 02319616 | OLMETEC PLUS | ORGANON CANADA INC. | Tablet | OLMESARTAN MEDOXOMIL 20 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed |
| 02461315 | PMS-OLMESARTAN | PHARMASCIENCE INC | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Marketed |
| 02461307 | PMS-OLMESARTAN | PHARMASCIENCE INC | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Marketed |
| 02443422 | SANDOZ OLMESARTAN | SANDOZ CANADA INCORPORATED | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Marketed |
| 02443414 | SANDOZ OLMESARTAN | SANDOZ CANADA INCORPORATED | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Marketed |
| 02442191 | TEVA-OLMESARTAN | TEVA CANADA LIMITED | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Marketed |
| 02442205 | TEVA-OLMESARTAN | TEVA CANADA LIMITED | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Marketed |
| 02443120 | TEVA-OLMESARTAN / HCTZ | TEVA CANADA LIMITED | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed |
| 02443112 | TEVA-OLMESARTAN / HCTZ | TEVA CANADA LIMITED | Tablet | OLMESARTAN MEDOXOMIL 20 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed |
| 02443139 | TEVA-OLMESARTAN / HCTZ | TEVA CANADA LIMITED | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed |
| 02475758 | AG-OLMESARTAN | ANGITA PHARMA INC. | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Dormant |
| 02475731 | AG-OLMESARTAN | ANGITA PHARMA INC. | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Dormant |
| 02453460 | APO-OLMESARTAN | APOTEX INC | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Dormant |
| 02453452 | APO-OLMESARTAN | APOTEX INC | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Dormant |
| 02453622 | APO-OLMESARTAN/HCTZ | APOTEX INC | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 25 MG | Dormant |
| 02453614 | APO-OLMESARTAN/HCTZ | APOTEX INC | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Dormant |
| 02453606 | APO-OLMESARTAN/HCTZ | APOTEX INC | Tablet | OLMESARTAN MEDOXOMIL 20 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Dormant |
| 02462044 | JAMP-OLMESARTAN HCTZ | JAMP PHARMA CORPORATION | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Dormant |
| 02462036 | JAMP-OLMESARTAN HCTZ | JAMP PHARMA CORPORATION | Tablet | OLMESARTAN MEDOXOMIL 20 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Dormant |
| 02462052 | JAMP-OLMESARTAN HCTZ | JAMP PHARMA CORPORATION | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 25 MG | Dormant |
| 02461285 | PMS-OLMESARTAN-HCTZ | PHARMASCIENCE INC | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market |
| 02461277 | PMS-OLMESARTAN-HCTZ | PHARMASCIENCE INC | Tablet | OLMESARTAN MEDOXOMIL 20 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market |
| 02461293 | PMS-OLMESARTAN-HCTZ | PHARMASCIENCE INC | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Pre Market |
| 02471361 | RIVA-OLMESARTAN | LABORATOIRE RIVA INC. | Tablet | OLMESARTAN MEDOXOMIL 40 MG | Cancelled Post Market |
| 02471353 | RIVA-OLMESARTAN | LABORATOIRE RIVA INC. | Tablet | OLMESARTAN MEDOXOMIL 20 MG | Cancelled Post Market |
| 02443406 | SANDOZ OLMESARTAN | SANDOZ CANADA INCORPORATED | Tablet | OLMESARTAN MEDOXOMIL 5 MG | Cancelled Pre Market |
| 02472082 | SANDOZ OLMESARTAN HCTZ | SANDOZ CANADA INCORPORATED | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Pre Market |
| 02472066 | SANDOZ OLMESARTAN HCTZ | SANDOZ CANADA INCORPORATED | Tablet | OLMESARTAN MEDOXOMIL 20 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market |
| 02472074 | SANDOZ OLMESARTAN HCTZ | SANDOZ CANADA INCORPORATED | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market |
| 02454106 | TEVA-OLMESARTAN/HCTZ | TEVA CANADA LIMITED | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market |
| 02454092 | TEVA-OLMESARTAN/HCTZ | TEVA CANADA LIMITED | Tablet | OLMESARTAN MEDOXOMIL 20 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market |
| 02454114 | TEVA-OLMESARTAN/HCTZ | TEVA CANADA LIMITED | Tablet | OLMESARTAN MEDOXOMIL 40 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 24785 | 2020-12-11 | Abbreviated New Drug Submission (ANDS) | NEW LABELLING MATERIALS AND LICENSING AGREEMENT BETWEEN TWO COMPANIES |
International API supply for OLMESARTAN MEDOXOMIL
28 valid EDQM Certificates of Suitability from 27 holders. 31 active FDA Drug Master Files.
Request a quote for OLMESARTAN/HCTZ